Heart Disease is in the Eye of the Beholder
March 2, 2021
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.
News Archive
News Archive - School of Medicine
Repurposed Arthritis Drug Did Not Significantly Improve Severe COVID-19 Pneumonia
March 1, 2021
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
NIH Awards UC San Diego $33 Million for Five COVID-19 Diagnostic Projects
February 25, 2021
UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from managing a large data center to expanding testing in disadvantaged communities.
Human Lung and Brain Organoids Respond Differently to SARS-CoV-2 Infection in Lab Tests
February 24, 2021
UC San Diego School of Medicine researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems. Their findings may help explain the wide variety in COVID-19 symptoms and aid the search for therapies.
You’ve Got to Move It, Move It
February 23, 2021
Research from Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego suggests that light-intensity physical activity, including shopping or a casual walk, may protect against mobility disability in older women.
Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic/Racial Groups
February 23, 2021
Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of aggressive prostate cancer.
Last-Itch Effort: Fighting the Bacteria That Exacerbate Eczema with Bacteria
February 22, 2021
Researchers at UC San Diego School of Medicine use bacteriotherapy to improve symptoms of atopic dermatitis.
First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer’s Disease
February 18, 2021
UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.
Chatter Between Cell Populations Drives Progression of Gastrointestinal Tumors
February 18, 2021
Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.
Genetics May Play Role in Determining Immunity to COVID-19
February 18, 2021
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
